BCRX
BioCryst Pharmaceuticals Inc.
$7.60
+$0.02(+0.26%)
48
Overall
30
Value
54
Tech
60
Quality
Market Cap
$1.61B
Volume
3.73M
52W Range
$6.00 - $11.31
Target Price
$20.40
EPS Estimates Overview
| Current Quarter | $0.04 | Next Quarter | $0.13 |
| Current Year | $0.2 | Next Year | $0.35 |
| QoQ Growth | +225.0% | YoY Growth | +75.0% |
| 3Y EPS CAGR | +25.3% | Target Price | $20.40 |
| Consensus | Buy | Upside | +168.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCRX | $7.60 | +0.3% | 3.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioCryst Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW